Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation

American Journal of Hematology

Volumn 82, Issue 12, 2007, Pages 1113-1115

  Takizawa, Jun ^a,c   Aoki, Sadao ^a   Kurasaki, Tori ^a   Higashimura, Masutaka ^a   Honma, Keiichiro ^a   Kitajima, Toshiki ^a   Momoi, Akihito ^a   Takahashi, Hidenobu ^a   Nakamura, Naoya ^b   Furukawa, Tatsuo ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VINDESINE;

ACUTE DISEASE; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DRUG INTERMITTENT THERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REMISSION; SKIN BIOPSY; SOUTHERN BLOTTING; T CELL LEUKEMIA; TREATMENT OUTCOME; VIRUS LOAD;

CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; HLA ANTIGENS; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; SKIN; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 36749009034     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21042     Document Type: Article

References (21)

1. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428-437.
2. Yamada Y, Tomonaga M, Fukuda Y, et al. A new G-CSF-supported combination chemotherapy, LSG-15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001;113:375-382.
3. Ishikawa T. Current status of therapeutic approaches to adult T-cell leukemia. Int J Haematol 2003;77:164-170.
4. Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukemia-lymphoma in Japan. Leuk Lymphoma 2003;44:611-618.
5. Tsukasaki K, Maeda T, Arimura K, et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: A case report and review of the literature. Bone Marrow Transplant 1999;23:87-89.
6. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogenic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:15-20.
7. Kami M, Hamaki T, Miyakoshi S, et al. Allogenic haematopoietic stem cell transplantation for the treatment of adult T-cell leukemia/lymphoma. Br J Haematol 2003;120:304-309.
8. Ogata M, Ogata Y, Imamura T, et al. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia. Bone Marrow Transplant 2002;30:699-701.
9. Kishi Y, Kami M, Oki Y, et al. Successful bone marrow transplantation for adult T-cell leukemia from a donor with oligoclonal proliferation of T-cells infected with human T-cell lymphotropic virus. Leuk Lymphoma 2001;42:819-822.
10. Nakase K, Hara M, Kozuka T, et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant 2006;37:41-44.
11. Hamaki T, Kami M, Igarashi M, et al. Non-myelooablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment. Leuk Lymphoma 2003;44:703-708.
12. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005;105:4143-4145.
13. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-1822.
14. Ooi J, Iseki T, Takahashi S, et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukemia in complete remission. Br J Haematol 2002;118:140-143.
15. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-491.
16. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005;19:829-834.
17. Weinthal JA, Goldman SC, Lenarsky C. Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant 2000;25:1311-1313.
18. Yoshimasu T, Manabe A, Tanaka R, et al. Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation. Bone Marrow Transplant 2002;30:41-44.
19. Ando T, Yujiri T, Tominaga T, et al. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: Successful engraftment with minimal toxicity. Eur J Haematol 2005;74:175-179.
20. Sakai R, Fujisawa S, Fujimaki K, et al. Long-term remission in a patient with hepatosplenic γδ T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006;37:537-538.
21. Tanimoto TE, Hirano A, Nagafuji K, et al. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocyte leukemia. Leukemia 2005;19:679-681.